Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Clinical trial NCT00860288 · COMPLETED
Trial details
- NCT number
- NCT00860288
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-03-01
- Enrollment
- 1988
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.